Literature DB >> 12505056

Molecular mechanisms of myocardial remodeling. The role of aldosterone.

Claude Delcayre1, Bernard Swynghedauw.   

Abstract

Cardiac remodeling, CR, is a complex and rather controversial issue and results from the, sometimes opposite, trophic effects of pure mechanical overload, and susceptibility factors, as senescence, aetiologies, as ischemia, and the neurohormonal reaction. The molecular mechanisms of CR are heritable and had, in the past, increased fitness, as such CR belongs to evolutionary medicine. Aldosterone production plays an important role in the remodeling of the heart. (i) There are numerous evidences that aldosterone induces fibrosis in all the cardiovascular system in the presence of high sodium diet. The aldosterone receptor is a transcriptional factor and the pathways that lead to aldosterone-induced fibrosis are multiple. Aldosterone induces the expression of the angiotensin II receptors subtype I and that of the glucocorticoid receptors. The RALES trial have recently evidenced a significant beneficial effect of spironolactone on both mortality and morbidity in heart failure, and a substudy has shown that these effects are linked to a reduction is fibrosis. (ii) An intracardiac production of aldosterone and corticosterone have been evidenced in the rat. Aldosterone production is regulated by low sodium/high potassium diets and by angiotensin II and is predominant in atria, cardiac production is low as compared to the adrenal production, nevertheless it results in high local concentrations, just like angiotensin II. In rats, myocardial infarction activates aldosterone production and this activation is prevented by losartan. Heart failure, in human, activates aldosterone production and is accompanied by a significant increase of the arteriovenous difference in aldosterone by the myocardium. To conclude (i) after a myocardial infarction local production of aldosterone and angiotensin II are likely to play a major role in regulating collagen turnover and fibrous tissue formation; (ii) during heart failure, the activation of adrenal and cardiovascular production of aldosterone belongs to the neurohormonal reaction and would play a detrimental role in producing reactive fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505056     DOI: 10.1006/jmcc.2002.2088

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  29 in total

Review 1.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

2.  Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction.

Authors:  Jirmar Radovan; Pelouch Vaclav; Widimsky Petr; Capek Jan; Andel Michal; Prusa Richard; Pechova Martina
Journal:  Mol Cell Biochem       Date:  2006-08-24       Impact factor: 3.396

3.  Impressive results for aldosterone antagonists in mild heart failure.

Authors:  JoAnn Lindenfeld
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

Review 4.  Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Andrea P Babick; Shelley Zieroth; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

5.  The stress-related hormone norepinephrine induced upregulation of Nix, contributing to ECM protein expression.

Authors:  Weili Liu; Xinxing Wang; Jingbo Gong; Zhusong Mei; Xiujie Gao; Yun Zhao; Jing Ma; Lingjia Qian
Journal:  Cell Stress Chaperones       Date:  2014-05-07       Impact factor: 3.667

Review 6.  Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease.

Authors:  Craig S Broberg; Luke J Burchill
Journal:  Int J Cardiol       Date:  2015-04-10       Impact factor: 4.164

7.  Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing.

Authors:  J Zhao; J Li; W Li; Y Li; H Shan; Y Gong; B Yang
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

8.  Angiotensin II-activated protein kinase D mediates acute aldosterone secretion.

Authors:  Brian A Shapiro; Lawrence Olala; Senthil Nathan Arun; Peter M Parker; Mariya V George; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2009-12-02       Impact factor: 4.102

Review 9.  Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.

Authors:  Abdallah Fayssoil; Olivier Nardi; David Orlikowski; Djillali Annane
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

10.  Eplerenone inhibits the intracrine and extracellular actions of angiotensin II on the inward calcium current in the failing heart. On the presence of an intracrine renin angiotensin aldosterone system.

Authors:  Walmor C De Mello; Yamil Gerena
Journal:  Regul Pept       Date:  2008-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.